NorthWest Biotherapeutics Inc (NWBO)

[hyperopia]

No, they’re not, “ready to manufacture 100,000 autologous vaccines a year.” (it will take years to ramp up to that level) From the latest 10-K:

Cognate BioServices' facility is approximately 80,000 square feet, and produces both the Company’s DCVax products and other clients’ products. We believe the current manufacturing facilities have the potential to produce DCVax for at least several thousand patients per year. We are also developing facilities for manufacturing in the U.K. for the European market. It is necessary for us to have manufacturing operations in Europe to meet the logistical requirements for European patients relating to the collection, delivery and processing of the patient’s blood draw containing the immune cells (for which the time window is too limited to reach the US manufacturing facility).